Recombinant human ANKS1B protein; Source: E. coli derived, PGEX-4T; Tag: GST; Domain: 446-510 aa of BC026313
Conjugate
Unconjugated
Applications
Application Notes
WB: 1:500-1:2000 IP: 0.5-4.0 μg for 1.0-3.0 mg of total protein lysate IHC: 1:50-1:500 IF/ICC: 1:50-1:500
General Notes
This product (Catalog No. DPABH-25413) is a rabbit-derived polyclonal antibody raised against human ANKS1B, targeting the amino acid region 446–510 of the protein. This antibody exhibits cross-reactivity with Human ANKS1B from mouse. It has been affinity purified by Protein A. ANKS1B also named as AIDA or cajalin 2 is a amino acid protein, which contains 7 ANK repeats, 1 PID domain and 2 SAM domains. ANKS1B localizes in cytoplasm and is highly expressed in brain and testis. ANKS1B exists as many alternatively spliced isoforms. It interacts with AbPP to play a role in brain development. AIDA-1 also interacts with coilin in Cajal bodies to regulate pre-mRNA splicing. DPABH-25413 is suitable for use in Western blot (WB) (1:500–1:2,000), IP (0.5-4.0 μg for 1.0-3.0 mg of total protein lysate), IHC (1:50–1:500), IF/ICC (1:50–1:500) applications. DPABH-25413 is supplied as a liquid formulation in PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. For long-term storage, keep at −20 °C. For short-term use, store at 2–8 °C. Avoid repeated freeze–thaw cycles to maintain antibody integrity and performance.
Target
Alternative Names
AIDA; AIDA 1; Amyloid-beta protein intracellular domain-associated protein 1; ANKS2; Ankyrin repeat and sterile alpha motif domain-containing protein 1B
My Review for Rabbit Anti-Human ANKS1B (a.a. 446-510) Polyclonal antibody
Creative Diagnostics products are for RESEARCH USE ONLY, please make sure your review is research based.
Required fields are marked with *
Terms and conditions:
We will select high-quality review customers and offer a $30 coupon for your next purchase.
All product reviews must be submitted in the English language.
Creative Diagnostics will not share any personal information of applicants, and all information will be treated with strict confidentiality and will not be sold or disclosed to a third party.